Internal Server Error

About MidCap Financial

MidCap Financial, established in 2008, is a private debt fund primarily based in Bethesda, United States. It specializes in financing Conventional Debt round of companies based in United States. Its portfolio includes 76 firms, spanning the Life Sciences, Enterprise Applications sectors.
As of Nov 2026, MidCap Financial has 1 unicorn under its belt and has witnessed 40 portfolio exits so far. Its most notable investments include companies like Forge Biologics, DNAnexus and Kashable.
Its latest investment was a $95M Conventional Debt round in Made by Gather on May 14, 2026 along with TCW.
Key Metrics
Founded Year
2008
Location
Bethesda, United States
Portfolio Companies
Stages of Investment
Conventional Debt, Venture Debt & 3 more
Locations of Investment
Unicorn in Portfolio

MidCap Financial's List of Top Investments

MidCap Financial has a portfolio of 76 companies, one of which is a Unicorn. Their most notable investments include Forge Biologics and DNAnexus.Their portfolio spans across United States, Canada, France and 2 more locations. They have invested in Life Sciences, Enterprise Applications, High Tech and 23 other sectors, across stages such as Conventional Debt, Venture Debt  and 3 more. Here is the list of top investments by MidCap Financial:
Developer of gene therapeutic solutions for treating multiple diseases. It has developed gene therapies that aim to help patients suffering from rare diseases. Products include FBX-101 which helps to treat infantile Krabbe diseases, FBX-201 for rare and monogenic diseases, and FBX-301 for rare & cancer diseases.

Key facts about Forge Biologics

DNAnexus provides cloud-based genome informatics and data management tools for enterprises and organizations that are engaged in the development and delivery of genomic medicine. The company’s platform enables the companies to analyze raw sequencing data; integrate genomic data with clinical and other phenotypic data, and collaborate seamlessly.

Key facts about DNAnexus

Provider of employer-sponsored program offering employees access to personal loans. The program integrates with human resource and payroll systems for loan administration. It facilitates access to credit and financial wellness resources. The program offers loans with repayment through payroll deductions.

Key facts about Kashable

  • Founded Year: 2013
  • Location: New York City (United States)
  • Stage: Series C
  • Total Funding till date: $123M
  • Employee Count: 100 as on Sep 30, 2026
  • Investors: Goldman Sachs, Nomura and 10 Others
  • Latest Funding Round: Series C, Apr 27, 2026, $*****
  • Highlight: Editors' Pick
Personal loans provider offering financial solutions with proprietary technology and AI. The company provides unsecured personal loans to consumers, leveraging advanced algorithms and data models to offer access to credit. They aim to create frictionless access to money, offering personalized solutions to meet unique financial needs. The company uses technology to paint a more complete picture of applicants, unlocking loan solutions. They offer various types of loans, including debt consolidation, home improvement, emergency, medical, online, and vacation loans. The company is committed to driving a better lending and borrowing experience by finding more reasons to say "yes." They also offer a mobile app for managing finances and monitoring credit scores. The company uses AI and data models to evaluate credit worthiness and provide access to fair credit. They are expanding their business through e-commerce platform integrations and commercial finance product development, introducing "qualify today, buy anywhere" technology. The website offers options to apply, login, check rates, and access a knowledge center.

Key facts about LendingPoint

Developer of multiplex protein stability platform for biologics. The company offers Optim, a multiplex protein stability platform for biologics that lets researchers measure multiple protein stability parameters, including denaturing temperature and aggregation onset temperature on multiple samples simultaneously. The company’s Optim platform is used for various applications, such as lead candidate selection and optimization, pre-formulation studies, candidate formulation, and stability studies.

Key facts about Unchained Labs

  • Founded Year: 2015
  • Location: Pleasanton (United States)
  • Stage: Acquired
  • Total Funding till date: $111M
  • Employee Count: 224 as on Sep 30, 2026
  • Investors: Canaan, Thecarlylegroup.fr and 6 Others
  • Latest Funding Round: Conventional Debt, Aug 10, 2021, $*****
  • Highlight: Acquired

MidCap Financial's Investments by Stage

MidCap Financial has made 52 investments in Conventional Debt stage with an average round size of $77.4M, 17 investments in Venture Debt stage with an average round size of $53.5M, 1 investment in PE stage, 1 investment in Series A stage with an average round size of $60M and 1 investment in Series E stage with an average round size of $58M.
Here are MidCap Financial's investments by stage:
Stage of entry
No. of Investments
Conventional Debt
52
Venture Debt
17
PE
1
Series A
1
Series E
1
Breakdown of MidCap Financial's investments by stage of entryConventional Debt (52)Venture Debt (17)
Note: We have considered here, only first round of investments

MidCap Financial's Investments by Sector

MidCap Financial has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, FinTech, Healthcare and High Tech. Notably, it has invested in 43 Enterprise (B2B) companies, 37 Tech companies, 15 Consumer (B2C) companies and at least 13 companies focusing on Software.
Here are MidCap Financial's investments by sector:
Sector
No. of Investments
Life Sciences
26
Enterprise Applications
11
FinTech
6
Healthcare
6
High Tech
6
Others
49
Breakdown of MidCap Financial's investments by sectorsLife Sciences (26)Enterprise Applic... (11)
Note: We have considered here, only first round of investments

MidCap Financial's Investments by Geography

MidCap Financial has made most investments in United States (63), followed by Canada where it has made 6 investments.
Here are MidCap Financial's investments by geography:
Country
No. of Investments
United States
63
Canada
6
France
1
Puerto Rico
1
United Kingdom
1
Breakdown of MidCap Financial's investments by countriesUnited States (63)Canada (6)
Note: We have considered here, only first round of investments

MidCap Financial's recent investments

MidCap Financial has made 3 investments in 2026 so far. Made by Gather and Northridge-Solutions are the latest among them.
Here are the most recent investments by MidCap Financial:
Date
Company
Location
Round Details
Round Amount
Co-Investors
May 14, 2026
United States
Conventional Debt
6418
 
Apr 30, 2026
-
Conventional Debt
9934
-
Apr 22, 2026
United States
Conventional Debt
7795
-
Aug 20, 2025
United States
Venture Debt
3647
-
Jun 04, 2025
United States
Conventional Debt
7078
-

Unicorns in MidCap Financial's Portfolio

MidCap Financial has 1 unicorn in its portfolio - Intarcia. The most recent unicorn in their portfolio is Intarcia which became a unicorn in 2014, 2 years before MidCap Financial first invested in it.
Here is a list of unicorns in MidCap Financial's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
47
Provider of osmotic pump for subcutaneous drug delivery
1995
Boston
Series J
gkrsvew

IPOs and Publicly Listed companies in MidCap Financial's Portfolio

14 of MidCap Financial's portfolio companies have become public. Sight Sciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2021 at marketcap of $1.09B and Nuo Therapeutics got listed on the OTC Markets (OTCMKTS) at marketcap of undefined.
Here are MidCap Financial's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jul 15, 2021
2019
Conventional Debt
7496
Feb 14, 2017
Feb 19, 2013
Conventional Debt
5691
Jul 25, 2016
Aug 01, 2016
Conventional Debt
9854
Feb 12, 2016
May 14, 2012
Venture Debt
1272
Dec 08, 2014
Jan 02, 2018
Conventional Debt
1314

Acquired companies in MidCap Financial's Portfolio

26 companies from MidCap Financial's portfolio have been acquired. The most recent acquisition was Paragon 28 in Jan 2025 by Zimmer Biomet for $*****.
Here are MidCap Financial's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jan 28, 2025
Jun 04, 2021
Conventional Debt
9224
Jan 02, 2025
Oct 04, 2022
Venture Debt
5955
Dec 16, 2024
-
-
3469
Aug 19, 2024
Feb 2016
Venture Debt
5147
Nov 13, 2023
Jan 10, 2022
Conventional Debt
1087

Co-investors of MidCap Financial

Over the past 18 years, 240 investors have co-invested in MidCap Financial's portfolio companies. This includes funds and angels.

  • Invested before MidCap Financial: RA Capital Management, TPG and 158 others have invested in rounds before MidCap Financial. There are 3 companies where RA Capital Management has invested before MidCap Financial and 3 companies where TPG has invested before MidCap Financial.
  • Top Co-investors of MidCap Financial: 27 investors entered a company along with MidCap Financial. These include investors like SVB (4 companies).
  • Invested after MidCap Financial: A total of 53 investors have invested in MidCap Financial's portfolio after their investments. Top Investors include Aisling Capital (1 company) and Blackstone (1 company).

Recent News related to MidCap Financial

•
Cerus Corporation Closes New Debt Facility of Up to $110 MillionBusiness Wire•Jun 08, 2026•Cerus, MidCap Financial
•
MidCap Financial Funds Acquisition of GT Mid AtlanticTime News•Apr 13, 2026•Gtmidatlantic, MidCap Financial
•
Tissue Regenix plans to delist following £17.5m fundraiseTheBusinessDesk.com•Dec 04, 2025•Tissue Regenix, MidCap Financial
View all news related to MidCap Financial

FAQs about MidCap Financial

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford